StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories medical Devices — Segment Cost of Products Sold ($M) ($M)

Postgres DB segment_values + Form 10-K/10-Q Segment Footnote (ASC 280 Significant Segment Expenses)

QuarterlyAnnual
Latest, Q2 2026
1,925
Period ended Jun 30, 2026
Change on a year earlier
+9.5%
1,758 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedical Devices — Segment Cost of Products Sold ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,925+9.5%Form 10-Q (filed 2026-07-28) ↗
Q1 2026Mar 31, 20261,814+13.5%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025-12,096+8.1%SEC Filing (0001628280-26-010185) ↗
Q3 2025Sep 30, 20251,767+10.1%Form 10-Q (filed 2025-10-29) ↗
Q2 2025Jun 30, 20251,758+8.1%Form 10-Q (filed 2025-07-30) ↗
Q1 2025Mar 31, 20251,598+3.3%Form 10-Q (filed 2025-04-30) ↗
Q4 2024Dec 31, 2024-11,187–SEC Filing (0001628280-26-010185) ↗
Q3 2024Sep 30, 20241,605–Form 10-Q (filed 2025-10-29) ↗
Q2 2024Jun 30, 20241,627–Form 10-Q (filed 2025-07-30) ↗
Q1 2024Mar 31, 20241,547–Form 10-Q (filed 2025-04-30) ↗

Breakdown

What makes up medical devices — segment cost of products sold ($m)

Cite this data

StockData. (2026). Abbott Laboratories Medical Devices — Segment Cost of Products Sold ($M) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-cogs-md

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.